Skip to main content
Log in

Clinical observation on treatment of diabetic nephropathy by tangweikang capsule

  • Published:
Chinese Journal of Integrated Traditional and Western Medicine Aims and scope Submit manuscript

Abstract Objective

To observe the effect of Tangweikang Capsule, (TWK) on diabetic nephropathy (DN).

Methods

The 119 DN patients were divided into two groups: the group of TWK treatment (n=78) and group of captopril (n=41) as the control, the dose of which was 50 mg/d. The treatment lasted for 12 weeks. The changes of symptom score, urinary microprotein series, blood glucose, renal function, etc. were observed.

Results

The total effective rate of the TWK group was 84.62% ; and that of the control group. was 70.73% , there was significant difference between the two groups (P<0.05). TWK treatment reduced the levels of blood glucose, blood lipid, serum creatinine, blood urea nitrogen, albumin, β -microglobulin and Tamm-Horsfall protein (P<0.05,P<0.01) in DN patients. The levels of triglyceride, angiotensin I , angiotensin II, atrial natriuretic polypeptide, prostaglandins, endothelin, type IV collagen and total cholesterol decreased and the level of high density lipoprotein-cholesterol increased in the serum of TWK-treated DN patients (P<0.05,P<0.01).

Conclusion

TWK exerted obviously ameliorating effect on renal function in DN patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wang Hy. Nephrology. 2nd edition. People’s Health Publishing House, 1996: 959-967.

  2. Mogensen CE. Management of early nephrology in diabetic patients. Ann Rev Med 1995; (46):79.

    Article  PubMed  CAS  Google Scholar 

  3. Syndrome differentiation, diagnosis and efficacy assessment standard. Shaanxi TCM 1988 ; (1):3rd page of inside cover.

  4. Ministry of Health. Guideline of clinical study on Chinese new drug in treating diabetes mellitus. 1987: 215-218.

  5. Ministry of Health. Guideline of clinical study on Chinese new drug in treating chronic glomerulonephritis. 1992:97.

  6. Lin L. Integrated traditional and western medicine diabetol- ogy. Beijing: Chinese Medical Science & Technoloy Press, 1999:394–409.

    Google Scholar 

  7. Yin J, Guo Lg. Modern research and clinical application of Chinese drugs. Beijing: Xueyuan Press, 1993:815,676, 1036.

    Google Scholar 

  8. Wang Xw. Progress in diagnosis and treatment of diabetic nephropathy. Chin Practical J Internal Med 1995; 15 (6): 361.

    Google Scholar 

  9. Liu Jf, Wen Jk. Progress in study of endothelin and renal function. Foreign Med, Physiology, Pathology and Clinical Fascicle 1997; 17(2): 145.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The study belonged, to State “Nine-Five” Key Projects (No. 96-906-07)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, L., Ni, Q., Gao, QJ. et al. Clinical observation on treatment of diabetic nephropathy by tangweikang capsule. CJIM 8, 19–23 (2002). https://doi.org/10.1007/BF02934612

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02934612

Key Words

Navigation